کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8292809 | 1536738 | 2018 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Astrocytes synthesize primary and cyclopentenone prostaglandins that are negative regulators of their proliferation
ترجمه فارسی عنوان
استروسیتها پروستاگلاندینهای اولیه و سیکلوپنتنون را سنتز می کنند که تنظیم کننده های منفی آنها است
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
FCSprostaglandin A2PGA2Peroxisome proliferator-activated receptor-γ (PPARγ)15-deoxy-delta-12,14-prostaglandin J215d-PGJ2LPSPPARDMEMDulbecco's modified Eagle's medium - Medal of Eagle اصلاح شده DulbeccoUPLC-MS/MS - UPLC-MS / MSBrdU - بروموداکسی اوریدینbromodeoxyuridine - برومودسوویریدینfetal calf serum - سرم گوساله جنینglial cells - سلول های گلیالultra-performance liquid chromatography-tandem mass spectrometry - طیف سنجی جرمی کروماتوگرافی مایع فوق عملکردیlipopolysaccharide - لیپوپلی ساکاریدCyclopentenone prostaglandins - پروستاگلاندین های سیکلوپدنتونprostaglandin - پروستاگلاندینهاperoxisome proliferator-activated receptor - گیرنده فعال فعال پروکسیوم
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
زیست شیمی
چکیده انگلیسی
Recently, the modulation of cellular inflammatory responses via endogenous regulators became a major focus of medically relevant investigations. Prostaglandins (PGs) are attractive regulatory molecules, but their synthesis and mechanisms of action in brain cells are still unclear. Astrocytes are involved in manifestation of neuropathology and their proliferation is an important part of astrogliosis, a cellular neuroinflammatory response. The aims of our study were to measure synthesis of PGs by astrocytes, and evaluate their influence on proliferation in combination with addition of inflammatory pathway inhibitors. With UPLC-MS/MS analysis we detected primary PGs (1410â¯Â±â¯36â¯pg/mg PGE2, 344â¯Â±â¯24 PGD2) and cyclopentenone PGs (cyPGs) (87â¯Â±â¯17 15d-PGJ2, 308â¯Â±â¯23 PGA2) in the extracellular medium after 24-h lipopolysaccharide (LPS) stimulation of astrocytes. PGs reduced astrocytic proliferation with the following order of potencies (measured as inhibition at 20â¯Î¼M): most potent 15d-PGJ2 (90%) and PGA2 (80%), > PGD2 (40%)â¯>â¯15d-PGA2 (20%)â¯>â¯PGE2 (5%), the least potent. However, PGF2α and 2-cyclopenten-1-one, and ciglitazone and rosiglitazone (synthetic agonists of PPARγ) had no effect. Combinations of cyPGs with SC-560 or NS-398 (specific anti-inflammatory inhibitors of cyclooxygenase-1 and -2, respectively) were not effective; while GW9662 (PPARγ antagonist) or MK-741 (inhibitor of multidrug resistance protein-1, MRP1, and CysLT1 receptors) amplified the inhibitory effect of PGA2 and 15d-PGJ2. Although concentrations of individual PGs and cyPGs are low, all of them, as well as primary PGs suppress proliferation. Thus, the effects are potentially additive, and activated PGs synthesis suppresses proliferation in astrocytes.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biochemical and Biophysical Research Communications - Volume 500, Issue 2, 2 June 2018, Pages 204-210
Journal: Biochemical and Biophysical Research Communications - Volume 500, Issue 2, 2 June 2018, Pages 204-210
نویسندگان
Dmitry V. Chistyakov, Sevil Grabeklis, Sergei V. Goriainov, Viktor V. Chistyakov, Marina G. Sergeeva, Georg Reiser,